• Oxurion announces second amendment to Negma Funding Program

    Thursday January 26th 2023

  • Connected-Pathology invests in novel Milestone automation processing instruments, simultaneously becoming Milestone’s prototype testing partner

    Tuesday January 24th 2023

  • Foreign companies invest record amount and create record number of jobs

    Monday January 16th 2023

  • FOx BIOSYSTEMS raises € 5.8 million in B-round financing to scale up its operations

    Friday January 13th 2023

  • ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank

    Tuesday January 10th 2023

  • FOx BIOSYSTEMS receives € 2.5 million EIC grant to accelerate the market introduction of unique EV analysis and isolation application

    Monday December 19th 2022

  • FIT stimulates market diversification with renewed subsidy

    Thursday December 1st 2022

  • BGV co-leads €10 million seed investment in neuroscience company FundaMental Pharma

    Thursday November 17th 2022

  • Your news here?

  • Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results

    Friday November 4th 2022

  • Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation of Medsenic valued at EUR 40 million

    Tuesday October 25th 2022

  • Orionis Biosciences secures $55 million financing to support advancement into clinic

    Wednesday October 19th 2022


Strategic Partners